This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Toru Takimoto, MD; Hiroshi Sato, PhD; Hisashi Ogura, MD; Tameo Miyazaki, MD

Arch Otolaryngol Head Neck Surg. 1987;113(5):510-513.

Abstract
• Cell fusion experiments using Epstein-Barr virus (EBV) obtained from nasopharyngeal carcinoma (NPC) hybrid cells (NPC-KT) were carried out to examine whether human adenoid epithelial cells (Ad-AH) could be fused with lymphoblastoid cells (BJAB, Raji, and A₂L) superinfected or infected by EBV, and if Ad-AH nuclei of the fused cells could express EBV-associated nuclear antigen. The presence of NPC EBV could induce EBV early antigen in all three lymphoblastoid cell lines. By autoradiography, we found that NPC EBV could induce cell fusion between Ad-AH cells and tritiated thymidine–labeled lymphoblastoid cells. In addition, we found that Ad-AH nuclei of the fused cells expressed EBV-associated nuclear antigen four days after NPC EBV-mediated cell fusion of Ad-AH cells with lymphoblastoid cells.

(Arch Otolaryngol Head Neck Surg 1987;113:510-513)

Author Affiliations
From the Department of Otolaryngology, School of Medicine (Drs Takimoto and Miyazaki), and the Department of Virology, Cancer Research Institute (Drs Sato and Ogura), Kanazawa (Japan) University.

Footnotes
Accepted for publication Nov 17, 1986.

Reprint requests to the Department of Otolaryngology, School of Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa 920, Japan (Dr Takimoto).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?